Clinical Trial Update: The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether alendronate combined with calcium and vitamin D improves bone mineral density in HIV-infected patients; the study has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Calcium carbonate (Calcium carbonate)
• Cholecalciferol (Vitamin D3)
• alendronate (alendronate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED